These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 7939535)
21. Antimicrobial resistance among Gram-negative bacteria isolated from intensive care units in a Cardiology Institute in Istanbul, Turkey. Kucukates E Jpn J Infect Dis; 2005 Aug; 58(4):228-31. PubMed ID: 16116256 [TBL] [Abstract][Full Text] [Related]
22. Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units. Wroblewska MM; Rudnicka J; Marchel H; Luczak M Int J Antimicrob Agents; 2006 Apr; 27(4):285-9. PubMed ID: 16545949 [TBL] [Abstract][Full Text] [Related]
23. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia. Kader AA; Kumar AK Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522 [TBL] [Abstract][Full Text] [Related]
24. Trends in antimicrobial susceptibility of Gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997-2007). Patzer JA; Dzierzanowska D; Turner PJ J Antimicrob Chemother; 2008 Aug; 62(2):369-75. PubMed ID: 18445575 [TBL] [Abstract][Full Text] [Related]
25. Cefepime use in a pediatric intensive care unit reduces colonization with resistant bacilli. Toltzis P; Dul M; O'Riordan MA; Salvator A; Rosolowski B; Toltzis H; Blumer JL Pediatr Infect Dis J; 2003 Feb; 22(2):109-14. PubMed ID: 12586972 [TBL] [Abstract][Full Text] [Related]
26. [Analysis of the etiological structure and dynamics of antibiotic resistance in the causative agents of suppurative inflammatory diseases in the patients at a large general hospital]. Kuznetsova SM; Samoĭlova LN; Speranskaia ON; Abadzhieva AN; Fomina IP Antibiotiki; 1984 Aug; 29(8):605-13. PubMed ID: 6486756 [TBL] [Abstract][Full Text] [Related]
27. Increasing antimicrobial resistance in gram-negative bacilli isolated from patients in intensive care units. Flournoy DJ; Reinert RL; Bell-Dixon C; Gentry CA Am J Infect Control; 2000 Jun; 28(3):244-50. PubMed ID: 10840345 [TBL] [Abstract][Full Text] [Related]
28. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006. Zhanel GG; DeCorby M; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; Mulvey MR; Hoban DJ; Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913 [TBL] [Abstract][Full Text] [Related]
29. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey. Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175 [TBL] [Abstract][Full Text] [Related]
30. Changes in antibiotic resistance of the most common Gram-negative bacteria isolated in intensive care units. Makedou KG; Tsiakiri EP; Bisiklis AG; Chatzidimitriou M; Halvantzis AA; Ntoutsou K; Alexiou-Daniel S J Hosp Infect; 2005 Jul; 60(3):245-8. PubMed ID: 15890431 [TBL] [Abstract][Full Text] [Related]
31. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing bacteria in intensive care units of Sanandaj general hospitals (Kurdistan, Iran). Ramazanzadeh R; Chitsaz M; Bahmani N Chemotherapy; 2009; 55(4):287-92. PubMed ID: 19521074 [TBL] [Abstract][Full Text] [Related]
32. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit]. Nikodemski T Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491 [TBL] [Abstract][Full Text] [Related]
33. Meropenem use and colonization by antibiotic-resistant Gram-negative bacilli in a pediatric intensive care unit. Toltzis P; Dul M; O'Riordan MA; Melnick D; Lo M; Blumer J Pediatr Crit Care Med; 2009 Jan; 10(1):49-54. PubMed ID: 19057450 [TBL] [Abstract][Full Text] [Related]
34. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp]. Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478 [TBL] [Abstract][Full Text] [Related]
35. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan. Saghir S; Faiz M; Saleem M; Younus A; Aziz H Indian J Med Microbiol; 2009; 27(4):341-7. PubMed ID: 19736404 [TBL] [Abstract][Full Text] [Related]
36. [Distribution of pathogen and resistance of nosocomial infections in the intensive care units]. Dai CM; Zhou JD; Wu Y; Qi Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):277-80. PubMed ID: 16706133 [TBL] [Abstract][Full Text] [Related]
37. A comparison of the antimicrobial resistance patterns of gram-negative bacilli isolated from community-private and university-affiliated hospitals from Puerto Rico. Vázquez GJ; Robledo IE; Arroyo A; Nadal E; Rodríguez R; Bermúdez M; Colón M P R Health Sci J; 2003 Sep; 22(3):265-71. PubMed ID: 14619453 [TBL] [Abstract][Full Text] [Related]
38. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study]. Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074 [TBL] [Abstract][Full Text] [Related]
39. Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Pfaller MA; Sader HS; Fritsche TR; Jones RN Diagn Microbiol Infect Dis; 2006 Sep; 56(1):63-8. PubMed ID: 16650951 [TBL] [Abstract][Full Text] [Related]
40. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital. Jung R; Fish DN; Obritsch MD; MacLaren R J Hosp Infect; 2004 Jun; 57(2):105-11. PubMed ID: 15183239 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]